Naveen Bhatia
Naveen Bhatia's purchase track record
Naveen Bhatia has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/15/2026 | EQPT | $242K | -15.1% | pending | — |
| 5/18/2022 | LFMD | $107K | +21.1% | +14.5% | +0.9% |
| 11/30/2021 | LFMD | $407K | -12.5% | -44.7% | -9.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
LifeMD Announces Preferred Dividend and AT&T Partnership. LifeMD declared a quarterly dividend on its Series A cumulative perpetual preferred stock. The company also announced a partnership with AT&T that will provide free memberships, with the potential to convert some users into paying patients. These developments come as the common stock trades near its recent support level and the firm carries a high trailing P/E.
Transaction History
| EQPT | ▲ Buy | Grant | 14,409 | $0 | 9/25/2026 | View on chart |
| EQPT | ▲ Buy | Open Market | 10,000 | $242K | 5/15/2026 | View on chart |
| EQPT | ▼ Sell | Other | 302,000 | — | 1/26/2026 | View on chart |
| EQPT | ▼ Sell | Other | 302,000 | — | 1/26/2026 | View on chart |
| LFMD | ▼ Sell | Other | 500 | $0 | 4/4/2024 | View on chart |
| LFMD | ▼ Sell | Other | 750 | $0 | 3/13/2024 | View on chart |
| LFMD | ▲ Buy | Grant | 225,000 | $0 | 6/14/2023 | View on chart |
| LFMD | ▲ Buy | Open Market | 50,000 | $107K | 5/18/2022 | View on chart |
| LFMD | ▲ Buy | Open Market | 50,000 | $213K | 12/1/2021 | View on chart |
| LFMD | ▲ Buy | Open Market | 50,000 | $194K | 11/30/2021 | View on chart |
| LFMD | ▼ Sell | Other | 96,349 | $169K | 9/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
EquipmentShare Refutes Short Report, Citi Cuts Target
EquipmentShare has publicly disputed a recent short seller report, labeling it misleading and defamatory. Amid this controversy, Citigroup maintained a Neutral rating but lowered its price target to $17. The stock is currently trading near its 52-week low, reflecting the uncertainty surrounding the company's financial claims.
EquipmentShare Refutes Short Report, Citi Cuts Target. EquipmentShare has publicly disputed a recent short seller report, labeling it misleading and defamatory. Amid this controversy, Citigroup maintained a Neutral rating but lowered its price target to $17. The stock is currently trading near its 52-week low, reflecting the uncertainty surrounding the company's financial claims.